Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computational ligand design.

J Apostolakis1, A Caflisch

  • 1University of Zürich, Switzerland.

Combinatorial Chemistry & High Throughput Screening
|July 27, 1999
PubMed
Summary
This summary is machine-generated.

Computational tools aid drug design by classifying molecules and estimating binding affinities using quantitative structure-activity relationships (QSAR), empirical energy functions, and free energy calculations. Structure-based design programs build ligands fragment-by-fragment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Silico Identification of JMJD3 Demethylase Inhibitors.

Journal of chemical information and modeling·2018
Same author

Iriomoteolides: novel chemical tools to study actin dynamics.

Chemical science·2018
Same author

Mechanism and Kinetics of Acetyl-Lysine Binding to Bromodomains.

Journal of chemical theory and computation·2015
Same author

Slow folding of cross-linked alpha-helical peptides due to steric hindrance.

The journal of physical chemistry. B·2010
Same author

CHARMM: the biomolecular simulation program.

Journal of computational chemistry·2009
Same author

Identification of the protein folding transition state from molecular dynamics trajectories.

The Journal of chemical physics·2009
Same journal

Exploring Spectral Graph Theory in Combinatorial Chemistry.

Combinatorial chemistry & high throughput screening·2026
Same journal

Unveiling the Cellular and Molecular Insights into Ulcerative Colitis Pathogenesis through Integrative Multi-omics and Functional Experiments.

Combinatorial chemistry & high throughput screening·2026
Same journal

Integrated Multi-Omics Identification of Novel Diagnostic Biomarkers and Immunometabolic Therapeutic Targets in Osteoporosis via Machine Learning.

Combinatorial chemistry & high throughput screening·2026
Same journal

Exploration and Prospects of Core Research Hotspots in the Mechanisms of Traditional Chinese Medicine for Treating Digestive System Malignancies Based on Bibliometrics.

Combinatorial chemistry & high throughput screening·2026
Same journal

Investigating the Potential Pharmacological Mechanisms of Huangqi in Allergic Rhinitis Using Network Pharmacology and Molecular Docking Strategies.

Combinatorial chemistry & high throughput screening·2026
Same journal

DNMT3A-driven Clonal Expansion of Hematopoiesis Influences Autoimmunity Mediated by Distinct Immune Cell Populations: A Mendelian Randomization Study.

Combinatorial chemistry & high throughput screening·2026
See all related articles

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Drug design relies on computational tools to analyze molecular properties and interactions.
  • Classifying compounds as drug-like or non-drug-like is crucial for efficient drug design.
  • Estimating binding affinities is a key theoretical challenge in ligand design.

Purpose of the Study:

  • To review computational tools used in drug design, emphasizing their limitations and merits.
  • To discuss the utility of compound classification for drug design.
  • To present and compare methods for estimating binding energies and describe structure-based ligand design.

Main Methods:

  • Quantitative Structure-Activity Relationships (QSAR): Models derived using genetic algorithms and neural networks, benefiting from high-throughput screening data.

Related Experiment Videos

  • Empirical Energy Functions: Models fitted to various complexes, offering broader applicability than standard QSAR.
  • Free Energy Calculations: Based on molecular dynamics simulations, providing a strong theoretical foundation.
  • Structure-Based Ligand Design: Programs that construct ligands fragment-by-fragment on a target structure.

    • Main Results:

    • Recent advancements in computational procedures and experimental techniques have significantly improved QSAR models.
    • Empirical energy functions have demonstrated considerable success in generating generalizable models.
    • Molecular dynamics-based free energy calculations are regaining interest due to recent developments.
    • Structure-based design programs offer a distinct approach to ligand construction compared to traditional docking.

    Conclusions:

    • A comprehensive review of computational drug design methodologies highlights their strengths and weaknesses.
    • The integration of various computational approaches, including QSAR, empirical functions, and structure-based design, is key to advancing drug discovery.
    • Further development in computational methods promises to enhance the efficiency and success rate of designing novel therapeutics.